BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4501868)

  • 21. The Walton report and its subsequent impact on cervical cancer screening programs in Canada.
    Worth AJ
    Obstet Gynecol; 1984 Feb; 63(2):135-9. PubMed ID: 6694805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differences in cervical cancer mass screening results in Greater-Helsinki area].
    Nieminen P; Tarkkanen J; Timonen T; Meyer B; Hakama M; Anttila A
    Duodecim; 2000; 116(22):2489-96. PubMed ID: 12053343
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined analysis of data from north-east Scotland and Iceland.
    Moss S
    IARC Sci Publ; 1986; (76):43-6. PubMed ID: 3570414
    [No Abstract]   [Full Text] [Related]  

  • 24. Cervical cancer in Kentucky.
    Friedell GH; Ross FE; Tucker TC; Cook CC; Doering DL; Hilgers R; Milburn CS; Pursell SH; Spires SE; Hinton M; Sorrell C; Edwards MJ
    J Ky Med Assoc; 2000 Sep; 98(9):398-405. PubMed ID: 11022405
    [No Abstract]   [Full Text] [Related]  

  • 25. A cervical cytology screening programme in the Thames area. Second and third years of study.
    McIndoe WA
    N Z Med J; 1966 Oct; 65(410):647-51. PubMed ID: 5224361
    [No Abstract]   [Full Text] [Related]  

  • 26. [A comparison between mass screening for uterine neck cancer in the Districts of Frederiksberg and Maribo].
    Koch F; Klinken L; Albrechtsen R
    Nord Med; 1971 Dec; 86(50):1534. PubMed ID: 5135061
    [No Abstract]   [Full Text] [Related]  

  • 27. Studs on population screening for early carcinoma of the uterine cervix.
    Bjerre B
    Acta Obstet Gynecol Scand Suppl; 1969; 6():1-140. PubMed ID: 5266058
    [No Abstract]   [Full Text] [Related]  

  • 28. Some results in the detection of cervical carcinoma.
    Mekuli S; Stambolovic B; Krajinovic S; Udicki S; Ducic S; Boskovic M
    Minerva Ginecol; 1971 Jan; 23(1):17-9. PubMed ID: 5553175
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mass screening for cervix carcinoma for the time being not extended to young pregnant or non-pregnant women].
    van Veen WA
    Ned Tijdschr Geneeskd; 1992 Nov; 136(47):2307-10. PubMed ID: 1461299
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of the effectiveness of cytologic screening for cervical cancer. I. Incidence and mortality trends in relation to screening.
    Dickinson L; Mussey ME; Soule EH; Kurland LT
    Mayo Clin Proc; 1972 Aug; 47(8):534-44. PubMed ID: 5049157
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preventive screening of the cervix uteri to prevent cervix cancer mortality].
    Sindram IS
    Ned Tijdschr Geneeskd; 1970 May; 114(22):916-21. PubMed ID: 5446493
    [No Abstract]   [Full Text] [Related]  

  • 34. Mortality from cervical cancer: can it be prevented now?
    Kessler II
    Compr Ther; 1976 Sep; 2(9):38-47. PubMed ID: 963967
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of the epidemiologic survey for the detection of cervical cancer in women of Lakavec and surroundings].
    Petrović M; Krajinović S; Udicki S; Petrović L; Radovanović Z; Vlajinac H; Ducić S
    Nar Zdrav; 1971 Sep; 27(9):332-5. PubMed ID: 5155792
    [No Abstract]   [Full Text] [Related]  

  • 36. Gynaecological mass screening in Finland.
    Timonen S
    Minerva Ginecol; 1971 Jan; 23(1):7-11. PubMed ID: 5553187
    [No Abstract]   [Full Text] [Related]  

  • 37. [Value of cytologic and gynecology screening tests].
    Sachs H
    Fortschr Med; 1974 Sep; 92(26):1037-41. PubMed ID: 4606060
    [No Abstract]   [Full Text] [Related]  

  • 38. [Importance of cancer of the cervix in Cataluña: considerations on an eventual screening program].
    Spagnolo de la Torre E; Segura Benedicto A; Vila Macau R; Andrés Martínez J; Sans Menéndez S
    Med Clin (Barc); 1984 Jan; 82(2):83-6. PubMed ID: 6708615
    [No Abstract]   [Full Text] [Related]  

  • 39. A cohort study of cervical cancer screening in British Columbia.
    Boyes DA; Morrison B; Knox EG; Draper GJ; Miller AB
    Clin Invest Med; 1982; 5(1):1-29. PubMed ID: 7116711
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of cervical cancer in a women's prison.
    Audet-Lapointe P
    Can Med Assoc J; 1971 Mar; 104(6):509-11. PubMed ID: 5549991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.